How might secondary active transport be leveraged in developing treatments for cystic fibrosis?

• A. By facilitating passive diffusion of water across cell membranes.
• B. By inhibiting all ion transport to prevent mucus buildup.
• C. By targeting ion transport mechanisms to improve chloride ion movement across cell membranes.
• D. By directly synthesizing the CFTR protein within cells.

Answer: (C)